Loading clinical trials...
Loading clinical trials...
This is a Phase 3 clinical study to evaluate the efficacy, safety, and immunogenicity of single/repeated injections of Eveotox in the treatment of moderate to severe glabellar lines. The study consist...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
JHM BioPharma (Tonghua) Co. , Ltd.
NCT07435428 · Moderate to Severe Glabellar Lines
NCT06481475 · Moderate to Severe Glabellar Lines
NCT06583486 · Moderate to Severe Glabellar Lines
NCT06151561 · Moderate to Severe Glabellar Lines
Peking Union Medical College Hospital
Beijing, Beijing Municipality
Peking University First Hospital
Beijing, Beijing Municipality
Peking University Third Hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions